Aurora Spine (OTCQB:ASAPF) announced today that it began the full commercial release of its SiLO TFX MIS system.
Carlsbad, California-based Aurora Spine designed the device for minimally invasive sacroiliac joint fixation. It treats conditions including sacroiliac joint disruptions and degenerative sacroiliitis. SiLO TFX includes a transfixing cone, an ilium screw, a sacrum screw and associated instrumentation.
The company says it developed the implants to transfix the sacrum and ilium providing stability for bony fusion. Aurora Spine director of operations Petra Lopizzo said the launch “is proceeding smoothly.” The company continues to deploy more instrument sets and implants into the field, Lopizzo added.
“We are excited to be in full launch of our game-changing treatment for patients suffering with SI joint pain and dysfunction,” said Trent Northcutt, Aurora Spine president, CEO and co-founder.
…